Literature DB >> 21046092

Virologic failure in an HIV-infected woman given desogestrel for excessive menstrual bleeding.

Dario Cattaneo1, Paola Meraviglia2, Rosangela Beretta2, Sara Baldelli1, Valeria Cozzi1, Greta Milani1, Emilio Clementi3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21046092     DOI： 10.1007/s00228-010-0934-y

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  12 in total

1.  Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers.

Authors:  Rosa F Yeh; Vincent E Gaver; Kristine B Patterson; Naser L Rezk; Faustina Baxter-Meheux; Michael J Blake; Joseph J Eron; Cheri E Klein; John C Rublein; Angela D M Kashuba
Journal:  J Acquir Immune Defic Syndr       Date:  2006-05       Impact factor: 3.731

2.  Effect of contraceptive methods on natural history of HIV: studies from the Mombasa cohort.

Authors:  Jared M Baeten; Ludo Lavreys; Manish Sagar; Joan K Kreiss; Barbra A Richardson; Bhavna Chohan; Dana Panteleeff; Kishorchandra Mandaliya; Jeckoniah O Ndinya-Achola; Julie Overbaugh; Tim Farley; Christina Mwachari; Craig Cohen; Tsungai Chipato; Unop Jaisamrarn; Orawan Kiriwat; Ann Duerr
Journal:  J Acquir Immune Defic Syndr       Date:  2005-03       Impact factor: 3.731

Review 3.  Pharmacogenomics of CYP3A: considerations for HIV treatment.

Authors:  Sukhwinder S Lakhman; Qing Ma; Gene D Morse
Journal:  Pharmacogenomics       Date:  2009-08       Impact factor: 2.533

Review 4.  Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

Authors:  Zdenek Hel; Elizabeth Stringer; Jiri Mestecky
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

5.  Effect of hormonal contraceptive use on plasma HIV-1-RNA levels among HIV-infected women.

Authors:  Helen E Cejtin; Lisa Jacobson; Gayle Springer; D Heather Watts; Alexandra Levine; Ruth Greenblatt; Kathryn Anastos; Howard L Minkoff; Leslie S Massad; Julie B Schmidt
Journal:  AIDS       Date:  2003-07-25       Impact factor: 4.177

6.  Estradiol and progesterone regulate HIV type 1 replication in peripheral blood cells.

Authors:  Susana N Asin; Alysha M Heimberg; Susan K Eszterhas; Christiane Rollenhagen; Alexandra L Howell
Journal:  AIDS Res Hum Retroviruses       Date:  2008-05       Impact factor: 2.205

7.  A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus.

Authors:  Elizabeth M Stringer; Christine Kaseba; Jens Levy; Moses Sinkala; Robert L Goldenberg; Benjamin H Chi; Inutu Matongo; Sten H Vermund; Mulindi Mwanahamuntu; Jeffrey S A Stringer
Journal:  Am J Obstet Gynecol       Date:  2007-08       Impact factor: 8.661

Review 8.  Hormonal contraception and HIV disease progression.

Authors:  Elizabeth Stringer; Erik Antonsen
Journal:  Clin Infect Dis       Date:  2008-10-01       Impact factor: 9.079

9.  Hormonal contraception and HIV-1 disease progression among postpartum Kenyan women.

Authors:  Barbra A Richardson; Phelgona A Otieno; Dorothy Mbori-Ngacha; Julie Overbaugh; Carey Farquhar; Grace C John-Stewart
Journal:  AIDS       Date:  2007-03-30       Impact factor: 4.177

10.  Cutting edge: progesterone regulates IFN-alpha production by plasmacytoid dendritic cells.

Authors:  Grant C Hughes; Sunil Thomas; Chang Li; Murali-Krishna Kaja; Edward A Clark
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.